July 16, 2019 09:56 AM EDTUpdated 10:47 AM
Deals

Roche's Genen­tech goes on deal spree, un­veil­ing third deal on the same day

Natalie Grover

Reporter

The busi­ness de­vel­op­ment ex­ec­u­tives at Roche’s Genen­tech have been busy shop­ping.

Af­ter an­nounc­ing tie-ups with So­sei Hep­tares and Sky­hawk on Tues­day, Genen­tech un­veiled …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times